Open AccessHsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B
Author(s) -
Jiangeng Yang,
Yuchen Liu,
Anbang He,
Yuhan Liu,
Jianting Wu,
Xinhui Liao,
Zhaojie Lv,
Feng Wang,
Hongbing Mei
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.19878
Subject(s) - bladder cancer , microrna , medicine , transfection , cancer research , cell growth , cancer , apoptosis , oncology , biology , cell culture , gene , biochemistry , genetics
Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom